Paul Jorgensen

Paul Jorgensen

ID: 1b839954-2619-30fb-68c4

/

Claimed Record

/

Organization: Norton Rose Fulbright

Higher costs awards coming to the Federal Court, including for pharma regulatory and IP disputes

Pharma in Brief · February 26, 2023

Pharma in Brief: The 2022 Year in Review

Pharma in Brief · January 25, 2023

Health Canada consulting on wide-ranging regulatory amendments for drugs and medical devices

Pharma in Brief · January 19, 2023

Ontario introduces biosimilar transition policy

Pharma in Brief · January 11, 2023

Federal Court of Appeal upholds decision invalidating claims to multiple sclerosis treatment regimen

Pharma in Brief · August 23, 2022

Practice Areas

Health Care and Life Sciences

Jurisdictions